Background/Aims: In this study, we aimed to evaluate the histopathological effects of thymoquinone treatment of the nasal mucosa in a rabbit model of allergic rhinitis, and we compared its effects with those of nasal mometasone furoate. Methods: A total of 24 male New Zealand rabbits were used. The animals were randomly assigned to one of four groups. Group 1 received no treatment, while group 2 underwent ovalbumin (OVA) sensitization only. Group 3 was the study group; after OVA sensitization, the rabbits were treated with intranasal thymoquinone. The group 4 rabbits received mometasone furoate for 7 days after OVA sensitization. Mucosal structures were stained with hematoxylin and eosin, while toluidine blue was used to stain mast cells. Apoptosis was evaluated using a TUNEL assay. Results: In the positive control groups, including the thymoquinone and intranasal mometasone furoate groups, intraepithelial and submucosal inflammation and goblet cell hypertrophy were significantly decreased compared to group 2 (p < 0.001). The cilial structure was normal, as was the chondrocyte structure in both treatment groups. Conclusion: This is the first study to evaluate the histopathological effects of thymoquinone in an allergic rhinitis model. Thymoquinone reduced allergic inflammation and may be valuable for treating allergic rhinitis. However, additional studies are needed.

Keywords:
Thymoquinone, Steroid, Nasal mucosa, Histopathology, Rhinitis
1.
Wallace DV, Dykewicz MS, Bernstein DI: The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008;122:81-84.
2.
Blaiss MS: Pediatric allergic rhinitis: physical and mental complications. Allergy Asthma Proc 2008;29:1-6.
3.
Bousquet PJ, Demoly P, Devillier P: Impact of allergic rhinitis symptoms on quality of life in primary care. Int Arch Allergy Immunol 2013;160:393-400.
4.
Bhattacharyya N: Functional limitations and workdays lost associated with chronic rhinosinusitis and allergic rhinitis. Am J Rhinol Allergy 2012;26:120-122.
5.
Corren J, Baroody FM, Pawankar R: Allergic and non-allergic rhinitis; in Adkinson NF, Bochner BS, Burks AW, et al (eds): Middletonn's Allergy Principles and Practice. Philadelphia, Elsevier Saunders, 2014, pp 664-685.
6.
Salib RJ, Howarth PH: Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis. Drug Saf 2003;26:863-893.
7.
Padhye S, Banerjee S, Ahmad A: From here to eternity - the secret of Pharaohs: therapeutic potential of black cumin seeds and beyond. Cancer Ther 2008;6:495-510.
8.
Ammar el SM, Gameil NM, Shawky NM: Comparative evaluation of anti-inflammatory properties of thymoquinone and curcumin using an asthmatic murine model. Int Immunopharmacol 2011;11:2232-2236.
9.
Keyhanmanesh R, Pejman L, Omrani H: The effect of single dose of thymoquinone, the main constituents of Nigella sativa, in guinea pig model of asthma. Bioimpacts 2014;4:75-81.
10.
Kalemci S, Cilaker Micili S, Acar T: Effectiveness of thymoquinone in the treatment of experimental asthma. Clin Ter 2013;164:155-158.
11.
Hayat K, Asim MB, Nawaz M: Ameliorative effect of thymoquinone on ovalbumin-induced allergic conjunctivitis in Balb/c mice. Curr Eye Res 2011;36:591-598.
12.
Duncker SC, Philippe D, Martin-Paschoud C: Nigella sativa (black cumin) seed extract alleviates symptoms of allergic diarrhea in mice, involving opioid receptors. PLoS One 2012;7:e39841.
13.
Erdurmus M, Yagci R, Yilmaz B: Inhibitory effects of topical thymoquinone on corneal neovascularization. Cornea 2007;26:715-719.
14.
Nathan RA: The burden of allergic rhinitis. Allergy Asthma Proc 2007;28:3-9.
15.
Bousquet PJ, Leynaert B, Neukirch F: Geographical distribution of atopic rhinitis in the European Community Respiratory Health Survey I. Allergy 2008;63:1301-1309.
16.
Bousquet J, Khaltaev N, Cruz AA: Allergic Rhinitis and its Impact on Asthma [ARIA] 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63:8-160.
17.
Ibanez MD, Valero AL, Montoro J: Analysis of comorbidities and therapeutic approach for allergic rhinitis in a pediatric population in Spain. Pediatr Allergy Immunol 2013;24:678-684.
18.
Weiner JM, Abramson MJ, Puy RM: Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998;317:1624-1629.
19.
Wilson AM, O'Byrne PM, Parameswaran K: Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis. Am J Med 2004;116:338-344.
20.
Brozek JL, Bousquet J, Baena-Cagnani CE: Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126:466-476.
21.
Darakhshan S, Bidmeshki Pour A, Hosseinzadeh Colagar A, Sisakhtnezhad S: Thymoquinone and its therapeutic potentials. Pharmacol Res 2015;95-96:138-158.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.